ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 102 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $98,850 | -5.0% | 29,864 | -6.2% | 0.00% | – |
| Q1 2024 | $104,071 | -6.7% | 31,826 | +0.2% | 0.00% | – |
| Q4 2023 | $111,495 | -65.3% | 31,765 | -33.9% | 0.00% | – |
| Q3 2023 | $321,161 | -92.6% | 48,078 | -90.7% | 0.00% | -100.0% |
| Q2 2023 | $4,323,711 | +54.0% | 515,341 | +82.3% | 0.00% | 0.0% |
| Q1 2023 | $2,807,271 | +63.3% | 282,706 | +14.4% | 0.00% | 0.0% |
| Q4 2022 | $1,719,475 | +41.3% | 247,051 | +8.4% | 0.00% | – |
| Q3 2022 | $1,217,000 | +1567.1% | 227,836 | +1291.4% | 0.00% | – |
| Q1 2022 | $73,000 | +9.0% | 16,375 | -2.3% | 0.00% | – |
| Q4 2021 | $67,000 | -67.3% | 16,753 | -28.3% | 0.00% | – |
| Q3 2021 | $205,000 | +3.0% | 23,358 | +33.1% | 0.00% | – |
| Q2 2021 | $199,000 | -95.7% | 17,551 | -97.2% | 0.00% | -100.0% |
| Q3 2020 | $4,629,000 | – | 624,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
| Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
| Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
| JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
| APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
| 683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
| EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
| Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
| WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |